CtrlK
BlogDocsLog inGet started
Tessl Logo

pseudonymizing-for-gdpr

Apply GDPR-grade pseudonymization to clinical or personal text with OpenMed, keeping a separately-held re-linkage key so the data can be controlled-re-linked later. Use when the user must process EU personal/health data under GDPR, asks for pseudonymization vs anonymization, needs Art. 4(5) / Art. 9 / Recital 26 alignment, wants a reversible mapping/key vault held apart from the data, or needs controlled re-linkage. Covers openmed.deidentify(policy="gdpr_pseudonymization", keep_mapping=True), storing the mapping in a separate key vault, reidentify() for authorized re-linkage, and retention. Pairs after extracting-pii-entities and configuring-privacy-policies.

74

Quality

91%

Does it follow best practices?

Run evals on this skill

Adds up to 20 points to the overall score

View guide

SecuritybySnyk

Passed

No findings from the security scan

SKILL.md
Quality
Evals
Security

Pseudonymizing for GDPR

Pseudonymization under the GDPR (Art. 4(5)) means processing personal data so it "can no longer be attributed to a specific data subject without the use of additional information" — provided that additional information (the re-linkage key) is "kept separately and is subject to technical and organisational measures." Crucially, pseudonymized data is still personal data (Recital 26): re-linkage is possible, so GDPR still applies. This is the opposite of anonymization, where re-identification is irreversibly prevented and the data falls outside the GDPR.

OpenMed implements this with a single reversible de-identification pass plus a mapping you store away from the data. This skill covers producing that mapping, vaulting the key separately, and re-linking under authorization.

When to use

  • You process EU residents' personal or special-category health data (Art. 9) and need a lawful, reversible safeguard rather than full anonymization.
  • You need to keep a record-linkage capability (e.g. to recontact a patient, reconcile longitudinal records, or honor a Subject Access Request) but must separate the linkage key from the working dataset.
  • A reviewer asks for the pseudonymization-vs-anonymization distinction in writing, or for the ENISA-style "additional information kept separately" control to be demonstrable.

Do not use this when the goal is irreversible anonymization for open release — there, drop the mapping entirely and gate residual risk with reviewing-reidentification-risk. Pseudonymization keeps a key; anonymization must not.

Quick start

import openmed

# Synthetic record — never run this skill's examples on real PHI.
note = "Patient Maria Schmidt (ID 4471) seen 2024-03-02; contact maria@example.de."

result = openmed.deidentify(
    note,
    method="replace",                 # realistic surrogates, not [LABEL] holes
    policy="gdpr_pseudonymization",   # bundled GDPR profile
    keep_mapping=True,                # produce the reversible re-linkage map
    consistent=True,                  # same input -> same surrogate in the doc
    seed=20240302,                    # cross-run reproducibility of surrogates
)

pseudonymized_text = result.deidentified_text   # safe to process / analyze
relink_key = result.mapping                      # surrogate -> original; SECRET

result.deidentified_text is the pseudonymized payload. result.mapping is the "additional information" GDPR Art. 4(5) requires be kept separately — it is the key that makes re-linkage possible, and therefore the most sensitive artifact in the whole flow.

Workflow

  1. Choose reversible pseudonymization, not masking. Use method="replace" with policy="gdpr_pseudonymization" and keep_mapping=True. Replacement surrogates keep the text usable for downstream NLP while remaining non-identifying. consistent=True (optionally with seed=) makes repeated mentions resolve to one stable surrogate so intra-document linkage survives.
  2. Split the data from the key immediately. The moment deidentify returns, route result.deidentified_text to your working store and result.mapping to a separate, access-controlled key vault — different system, different credentials, different backups. Never persist them in the same row, file, bucket, or log line. This separation is the technical-and-organisational measure that makes the data pseudonymized rather than just "personal data with PII in it."
  3. Process the pseudonymized text freely. Run analyze_text, analytics, model training, or transfer on deidentified_text. The key never leaves the vault during ordinary processing.
  4. Re-link only under authorization. When a lawful basis exists (e.g. an authorized SAR or recontact), fetch the mapping from the vault and call openmed.reidentify(deidentified_text, mapping). Log that a re-linkage happened (who, when, why, record id) — but never log the restored plaintext.
  5. Apply retention to the key. The mapping has its own retention clock. When the lawful basis for re-linkage ends, destroy the mapping. Once the key is irreversibly gone and no other re-identification path remains, the remaining text approaches anonymization and GDPR obligations shrink accordingly. Verify that claim with reviewing-reidentification-risk before relying on it.

Hand-off to / from OpenMed

  • From extracting-pii-entities / configuring-privacy-policies: confirm the detector recall and the active policy profile before pseudonymizing, since any identifier the detector misses leaks into deidentified_text.
  • OpenMed call: Python from openmed import deidentify, reidentify; the same capability is exposed as MCP tool openmed_deidentify and REST /deidentify. Pass policy="gdpr_pseudonymization", keep_mapping=True.
  • To auditing-deid-leakage: scan result.deidentified_text for residual identifiers before it leaves the boundary — pseudonymization is only as strong as detection.
  • To reviewing-reidentification-risk: quasi-identifier (age, ZIP, dates) re-identification still applies to pseudonymized data; score k-anonymity on the output and document residual risk.

Edge cases & gotchas

  • Pseudonymized ≠ anonymized. As long as mapping exists anywhere, the data is personal data under Recital 26. Do not market a keep_mapping=True output as "anonymous."
  • The mapping is the crown jewel. A leaked mapping re-identifies everything at once. Treat it as the highest-sensitivity secret: encrypt at rest, restrict access, audit reads.
  • Surrogates can still carry quasi-identifiers. method="replace" swaps the identifier text, but free-text age, rare diagnosis, ZIP, or admission dates remain. Pseudonymization does not address singling-out; pair with QI risk scoring.
  • Reproducibility cuts both ways. A fixed seed makes surrogates stable across runs (good for linkage) but means an attacker who learns the seed and algorithm can reproduce surrogates — keep the seed with the key, not the data.
  • Special-category data (Art. 9). Health data needs a lawful basis before processing; pseudonymization is a safeguard, not a lawful basis on its own.
  • Local-first. Run entirely on-device. Do not send EU personal data to a cloud de-identification service to satisfy GDPR — that may itself be a transfer.

Standards & references

  • GDPR Art. 4(5) — definition of pseudonymization: https://gdpr-info.eu/art-4-gdpr/
  • GDPR Art. 9 — processing of special categories (health) data: https://gdpr-info.eu/art-9-gdpr/
  • GDPR Recital 26 — pseudonymous data is personal data; anonymization test: https://gdpr-info.eu/recitals/no-26/
  • ENISA, Pseudonymisation techniques and best practices (2019): https://www.enisa.europa.eu/publications/pseudonymisation-techniques-and-best-practices
  • EDPB Guidelines on pseudonymisation (01/2025): https://www.edpb.europa.eu/
Repository
maziyarpanahi/openmed
Last updated
First committed

Is this your skill?

If you maintain this skill, you can claim it as your own. Once claimed, you can manage eval scenarios, bundle related skills, attach documentation or rules, and ensure cross-agent compatibility.